In the 19 IDH-mt astrocytoma cases, TP53 (95%), ATRX (63%), MLL2 (21%), and CDKN2A/B homozygous deletion (16%) were detected (Figure 2B). Here, TP53 is linked to astrocytoma (excluding glioblastoma).